Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 6;10(1):8.
doi: 10.1186/1476-9255-10-8.

Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery

Affiliations

Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery

Michail Yaroustovsky et al. J Inflamm (Lond). .

Abstract

Background: To evaluate the prognostic value of endotoxin activity assay (EAA) in adult patients with suspected or proven severe sepsis after cardiac surgery

Methods: Blood samples taken from 81 patients immediately after the diagnosis of severe sepsis were tested with the EAA. Patients were divided into 3 groups: low (<0.4, n = 20), moderate (0.4-0.59, n = 35) and high (≥0.6, n = 26) EAA levels.

Results: Gram-negative bacteraemia was found in 19/55 (35%) of cases with ЕАА <0.6 and in 11/26 (42%) of cases with higher ЕАА, p = 0.67. Mortality at 28 days in Groups 1, 2 and 3 was 20%, 43% and 54%, respectively. Patients with an EAA higher than 0.65 had a higher 28-day mortality than those with lower EAA values (18/26 - 69% vs. 19/55 - 34.5%; p = 0.0072). ROC analysis for the prediction of 28-day mortality revealed an AUC for APACHE II scores, EAA and PCT of 0.81, 0.73 and 0.66, respectively.

Conclusions: EАА might be useful for recognising patients who have an increased risk of mortality due to severe sepsis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Receiver operating characteristic curve of serum levels of EAA, LAL, PCT and APACHE II in predicting 28-day mortality.

References

    1. Opal SM. Endotoxins and other sepsis triggers. Contrib Nephrol. 2010;167:14–24. - PubMed
    1. Bryans TD, Braithwaite C, Broad J, Cooper JF, Darnell KR, Hitchins VM, Karren AJ, Lee PS. Bacterial endotoxin testing: a report on the methods, background, data, and regulatory history of extraction recovery efficiency. Biomed Instrum Technol. 2004;38(1):73–78. doi: 10.2345/0899-8205(2004)38[73:BETARO]2.0.CO;2. - DOI - PubMed
    1. Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, Romaschin AD, Derzko AN. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care. 2002;6(4):342–382. doi: 10.1186/cc1522. - DOI - PMC - PubMed
    1. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A. MEDIC study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis. 2004;190(3):527–534. doi: 10.1086/422254. - DOI - PubMed
    1. Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, Marshall JC. Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock. 2007;28(5):524–529. - PubMed

LinkOut - more resources